GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemCell Institute (TSE:7096) » Definitions » Net Income Including Noncontrolling Interests

StemCell Institute (TSE:7096) Net Income Including Noncontrolling Interests : 円311 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is StemCell Institute Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

StemCell Institute's Net Income Including Noncontrolling Interests for the three months ended in Sep. 2024 was 円0 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Sep. 2024 was 円311 Mil.

StemCell Institute Net Income Including Noncontrolling Interests Historical Data

The historical data trend for StemCell Institute's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StemCell Institute Net Income Including Noncontrolling Interests Chart

StemCell Institute Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial 277.49 62.37 133.73 198.03 310.98

StemCell Institute Quarterly Data
Mar18 Mar19 Dec19 Mar20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 75.69 84.11 95.19 56.00 -

StemCell Institute Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円311 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

StemCell Institute Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of StemCell Institute's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

StemCell Institute Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemCell Institute (TSE:7096) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
TSE:4888 TSE:4880 TSE:4588 TSE:4579 TSE:4583 TSE:206A TSE:4978 TSE:4571 TSE:190A TSE:177A VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
Shimbashi, Minato-ku, Tamuracho Building, Matsuoka, Tokyo, JPN, 105-0004
Website
https://www.stemcell.co.jp
StemCell Institute is engaged in Cell bank business that separates and stores cord blood for regenerative medicine. Cord blood is the baby's blood contained in the umbilical cord and placenta that connects mother and baby. In its umbilical cord blood storage business, upon receiving notification from customers who have contracted, umbilical cord blood collected at obstetric facilities throughout Japan is collected, transported to the company's own cell processing center within 48 hours, and it provides a service to store cells at ultra-low temperature after separating cells from blood.

StemCell Institute Headlines

No Headlines